Prevalence of Human Papillomavirus (HPV) types in cervical cancer 2003–2008 in Stockholm, Sweden, before public HPV vaccination

By Du Juan   Näsman Anders   Carlson Joseph W.   Ramqvist Torbjörn   Dalianis Tina  

Acta Oncologica, Vol. 50, Iss. 8, 2011-11 ,pp. : 1215-1219

Informa Healthcare

Access to resources Recommend Favorite

Clinical and Economic Implications of Adding HPV Tests to the Routine Cytology Follow-Up and Management of Patients with Histologically Defined Cervical Intraepithelial Neoplasia Grade 1

By Gamzu R.   Almog B.   Levin I.   Fainaru O.   Niv J.   Lessing J.B.   Bar-Am A.  

Gynecologic Oncology, Vol. 86, Iss. 2, 2002-08 ,pp. : 129-133

Academic Press

Access to resources Recommend Favorite

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

By Flores Yvonne  

Cancer Causes and Control, Vol. 22, Iss. 2, 2011-02 ,pp. : 261-272

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico

By Salmerón J.  

Cancer Causes and Control, Vol. 14, Iss. 6, 2003-08 ,pp. : 505-512

Springer Publishing Company

Access to resources Recommend Favorite

Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer

By Berkhof Johannes   Bogaards Johannes A  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1817-1821

Future Medicine

Access to resources Recommend Favorite